Skip to main content
Caplight Logo









MediSpan Co., Ltd.

MediSpan Co., Ltd.

Private
South KoreaHealthcare & Life Scienceshttp://medispan.co.kr/en/

Last Round

Grant

Sep 11, 2024

Total Funding Raised

$7.44M

Company Overview

MediSpan Co., Ltd. is a biotechnology company that develops geroprotective medical therapies and drugs for treating age-related diseases and improving healthspan.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

geroscienceanti-aging therapylongevity biotechmucosal immunityTLR5 modulatorimmunosenescencemicrobiome therapeuticsdrug discoveryage-related diseaseimmune adjuvanttissue regenerationbiotech R&Dpreclinical drug developmentgeriatric medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

MediSpan Co., Ltd. Comparables

Compare MediSpan Co., Ltd. with similar companies based on industry and business-model similarity.

MediSpan Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
HaplScience
80%
Deciduous Therapeutics
77%
Immunis, Inc.
72%

MediSpan Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantSep 11, 2024
Series AMay 13, 2021
Pre SeedMar 1, 2021

MediSpan Co., Ltd. Investors

Notable investors and investment history

MediSpan Co., Ltd. investors
InvestorRounds
DSC InvestmentPre Seed, Series A
STASSETS INVESTMENTSeries A
SchmidtPre Seed
Tigris InvestmentSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 11, 2024

    $150K grant round completed.

  • May 13, 2021

    $5.8M round led by STASSETS INVESTMENT

MediSpan Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

MediSpan Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about MediSpan Co., Ltd.'s valuation, stock price, and market status.

Is MediSpan Co., Ltd. a public or private company?

MediSpan Co., Ltd. is a private company.

What is the current stock price of MediSpan Co., Ltd.?

MediSpan Co., Ltd. is a private company with no public stock price. Caplight tracks MediSpan Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates to Caplight users.

How much is MediSpan Co., Ltd. worth (valuation)?

Valuation information for MediSpan Co., Ltd. is not publicly available.

Can I buy MediSpan Co., Ltd. stock?

MediSpan Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was MediSpan Co., Ltd.'s last funding round?

MediSpan Co., Ltd.'s most recent funding round was Grant on September 11, 2024.

Who are the main investors in MediSpan Co., Ltd.?

Key investors in MediSpan Co., Ltd. include DSC Investment, STASSETS INVESTMENT, Schmidt, Tigris Investment.

Will MediSpan Co., Ltd. IPO soon?

No public IPO plans have been announced for MediSpan Co., Ltd..

How can I track MediSpan Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor MediSpan Co., Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSouth Korea
Year Founded2020
Last FundingSep 11, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?